Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-Rüdiger Burmester

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Rheumatology|September 3, 2016
Targeting GM-CSF in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd-Rüdiger Burmester
Deutsches Arzteblatt International|December 17, 2021
The Safety of Antirheumatic DrugsJohanna Mucke, Hans-Uwe Simon, Gerd Rüdiger Burmester
Rheumatology (Oxford, England)|May 5, 2021
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Zeitschrift Fur Rheumatologie|December 1, 2020
[The what, the how and the why in rheumatological research]Kirsten Minden, Andreas Radbruch, Gerd-Rüdiger Burmester, et al.
Die Naturwissenschaften|November 19, 2002
Stem cells for regenerative medicine: advances in the engineering of tissues and organsJochen Ringe, Christian Kaps, Gerd-Rüdiger Burmester, et al.
Arthritis Research & Therapy|October 7, 2005
Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosusMaren Henneken, Thomas Dörner, Gerd-Rüdiger Burmester, et al.
RMD Open|October 29, 2015
Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?Frank Buttgereit, Gerd-Rüdiger Burmester, Johannes W J Bijlsma
Rheumatology Advances in Practice|July 17, 2023
Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's diseaseRobert Biesen, Tobias Alexander, Gerd-Rüdiger Burmester, et al.
Arthritis and Rheumatism|November 6, 2004
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of actionFrank Buttgereit, Rainer H Straub, Martin Wehling, et al.
Rheumatology and Therapy|April 19, 2020
Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in GermanyKlaus Krüger, Gerd Rüdiger Burmester, Siegfried Wassenberg, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Rheumatology|September 3, 2016
Targeting GM-CSF in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd-Rüdiger Burmester
Deutsches Arzteblatt International|December 17, 2021
The Safety of Antirheumatic DrugsJohanna Mucke, Hans-Uwe Simon, Gerd Rüdiger Burmester
Rheumatology (Oxford, England)|May 5, 2021
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritisAli Berkant Avci, Eugen Feist, Gerd Rüdiger Burmester
Zeitschrift Fur Rheumatologie|December 1, 2020
[The what, the how and the why in rheumatological research]Kirsten Minden, Andreas Radbruch, Gerd-Rüdiger Burmester, et al.
Die Naturwissenschaften|November 19, 2002
Stem cells for regenerative medicine: advances in the engineering of tissues and organsJochen Ringe, Christian Kaps, Gerd-Rüdiger Burmester, et al.
Arthritis Research & Therapy|October 7, 2005
Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosusMaren Henneken, Thomas Dörner, Gerd-Rüdiger Burmester, et al.
RMD Open|October 29, 2015
Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?Frank Buttgereit, Gerd-Rüdiger Burmester, Johannes W J Bijlsma
Rheumatology Advances in Practice|July 17, 2023
Recovery of hearing loss, depression and erosive polyarthritis after diagnosis of Whipple's diseaseRobert Biesen, Tobias Alexander, Gerd-Rüdiger Burmester, et al.
Arthritis and Rheumatism|November 6, 2004
Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of actionFrank Buttgereit, Rainer H Straub, Martin Wehling, et al.
Rheumatology and Therapy|April 19, 2020
Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in GermanyKlaus Krüger, Gerd Rüdiger Burmester, Siegfried Wassenberg, et al.
Pageof 18